<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03684174</url>
  </required_header>
  <id_info>
    <org_study_id>2018-00136</org_study_id>
    <nct_id>NCT03684174</nct_id>
  </id_info>
  <brief_title>Non-Contact Air Tonometry (Topcon CT-1®) Versus Goldmann</brief_title>
  <official_title>Non-Contact Air Tonometry (Topcon CT-1®) Versus Goldmann Applanation Tonometry: a Device Comparison Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective device comparison study with 58 healthy eyes, the Topcon CT-1® showed
      statistically significant elevated intraocular pressure measurements compared to the gold
      standard Goldmann application tonometry.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction:

      Intraocular pressure (IOP) measurement is crucial in glaucoma diagnosis and treatment. We
      compared a non-contact air tonometer (Topcon CT-1®) with the gold standard Goldmann
      Applikation tonometer (GAT).

      Methods:

      In this prospective, mono centric device comparison study, only healthy eyes were enrolled.
      IOP was measured three times with the Topcon CT-1® followed by three times GAT. Mean IOP was
      calculated and compared with a paired t-test, a linear regression and a Bland-Altman
      analysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Actual">October 31, 2017</completion_date>
  <primary_completion_date type="Actual">October 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of GAT with air tonometry Topcon CT1</measure>
    <time_frame>7 months</time_frame>
    <description>Difference in mmHg between these two devices</description>
  </primary_outcome>
  <enrollment type="Actual">58</enrollment>
  <condition>Glaucoma</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intraocular pressure measurement</intervention_name>
    <description>Pressure tip or air puff is applied on eye</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Healthy volunteers who agreed to be included in the study and were able to comply with the
        measurement procedures

        Exclusion criteria were cor-neal abnormalities (such as oedema, scars or dystrophies,
        astigmatism,hyperopia or myopia &gt; 3 dioptres), a history of ocular surgery or recent(&lt;47
        weeks) ocular disorder.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascal B Knecht, MD PD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Augenpraxis Centerpassage</name>
      <address>
        <city>Wettingen</city>
        <state>AG</state>
        <zip>5430</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30.</citation>
    <PMID>12049575</PMID>
  </reference>
  <reference>
    <citation>Jorge J, González-Méijome JM, Díaz-Rey JA, Almeida JB, Ribeiro P, Parafita MA. Clinical performance of non-contact tonometry by Reichert AT550 in glaucomatous patients. Ophthalmic Physiol Opt. 2003 Nov;23(6):503-6.</citation>
    <PMID>14622352</PMID>
  </reference>
  <reference>
    <citation>Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003 Jan;121(1):48-56.</citation>
    <PMID>12523884</PMID>
  </reference>
  <reference>
    <citation>Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006 Mar;90(3):262-7.</citation>
    <PMID>16488940</PMID>
  </reference>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 17, 2018</study_first_submitted>
  <study_first_submitted_qc>September 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2018</study_first_posted>
  <last_update_submitted>September 24, 2018</last_update_submitted>
  <last_update_submitted_qc>September 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tonometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

